These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 26229021)

  • 41. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
    Shi W; Kato H; Perez-Ordonez B; Pintilie M; Huang S; Hui A; O'Sullivan B; Waldron J; Cummings B; Kim J; Ringash J; Dawson LA; Gullane P; Siu L; Gillison M; Liu FF
    J Clin Oncol; 2009 Dec; 27(36):6213-21. PubMed ID: 19884544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
    Bussu F; Sali M; Gallus R; Vellone VG; Zannoni GF; Autorino R; Dinapoli N; Santangelo R; Martucci R; Graziani C; Miccichè F; Almadori G; Galli J; Delogu G; Sanguinetti M; Rindi G; Valentini V; Paludetti G
    Br J Cancer; 2013 Mar; 108(5):1157-62. PubMed ID: 23403821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis.
    Gao G; Chernock RD; Gay HA; Thorstad WL; Zhang TR; Wang H; Ma XJ; Luo Y; Lewis JS; Wang X
    Int J Cancer; 2013 Feb; 132(4):882-90. PubMed ID: 22821242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx.
    Chernock RD; Wang X; Gao G; Lewis JS; Zhang Q; Thorstad WL; El-Mofty SK
    Mod Pathol; 2013 Feb; 26(2):223-31. PubMed ID: 22996374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus and head and neck squamous cell carcinomas in the South-East of France: prevalence, viral expression, and prognostic implications.
    Gavid M; Pillet S; Pozzetto B; Oriol M; Dumollard JM; Timoshenko AP; Martin C; Prades JM
    Acta Otolaryngol; 2013 May; 133(5):538-43. PubMed ID: 23350597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
    Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
    Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and expression of human papillomavirus in 53 patients with oral tongue squamous cell carcinoma.
    Tsimplaki E; Argyri E; Xesfyngi D; Daskalopoulou D; Stravopodis DJ; Panotopoulou E
    Anticancer Res; 2014 Feb; 34(2):1021-5. PubMed ID: 24511049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma.
    Guo M; Khanna A; Dhillon J; Patel SJ; Feng J; Williams MD; Bell DM; Gong Y; Katz RL; Sturgis EM; Staerkel GA
    Cancer Cytopathol; 2014 Feb; 122(2):96-103. PubMed ID: 24339259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas--a tissue microarray study utilizing E6/E7 mRNA in situ hybridization.
    Lewis JS; Ukpo OC; Ma XJ; Flanagan JJ; Luo Y; Thorstad WL; Chernock RD
    Histopathology; 2012 May; 60(6):982-91. PubMed ID: 22360821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas.
    Augustin J; Outh-Gauer S; Mandavit M; Gasne C; Grard O; Denize T; Nervo M; Mirghani H; Laccourreye O; Bonfils P; Bruneval P; Veyer D; Péré H; Tartour E; Badoual C
    Hum Pathol; 2018 Aug; 78():63-71. PubMed ID: 29684499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.
    Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
    Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laryngeal Cancer, HPV DNA vs E6/E7 mRNA Test: A Systematic Review.
    Fusconi M; Campo F; Gallo A; Zambetti G; Martellucci S; Seccia A; de Vincentiis M
    J Voice; 2017 Mar; 31(2):248.e1-248.e5. PubMed ID: 27613249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.
    Schroeder L; Boscolo-Rizzo P; Dal Cin E; Romeo S; Baboci L; Dyckhoff G; Hess J; Lucena-Porcel C; Byl A; Becker N; Alemany L; Castellsagué X; Quer M; León X; Wiesenfarth M; Pawlita M; Holzinger D
    Eur J Cancer; 2017 Mar; 74():73-81. PubMed ID: 28335889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity.
    El-Mofty SK; Lu DW
    Am J Surg Pathol; 2005 Oct; 29(10):1367-72. PubMed ID: 16160480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
    Hoffmann M; Ihloff AS; Görögh T; Weise JB; Fazel A; Krams M; Rittgen W; Schwarz E; Kahn T
    Int J Cancer; 2010 Oct; 127(7):1595-602. PubMed ID: 20091864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.